Non-Hodgkin's lymphoma in childhood

Article Abstract:

Survival rates in children with non-Hodgkin's lymphoma have increased substantially in the past 30 years. Non-Hodgkin's lymphoma is a type of cancer that affects the B cells and T cells of the immune system. Most children develop tumors in their chest, abdomen or head and neck. Two-thirds of all children diagnosed with non-Hodgkin's lymphoma have advanced or metastatic disease. Chemotherapy is the mainstay of treatment for non-Hodgkin's lymphoma. Those with limited disease can often be cured with just 9 to 26 weeks of chemotherapy. Five-year survival rates in these children approach 95%. Children with advanced disease must be treated longer and their survival rates are lower. However, 75% of these children will also be cured. Children who relapse or never go into remission have a poor prognosis, but may be candidates for a bone marrow transplant. Unfortunately, many children develop diseases that are directly caused by the chemotherapy.

Care and treatment, Non-Hodgkin's lymphomas

---

Radiotherapy for glioblastoma in the elderly

Article Abstract:

Trials conducted reveal that in elderly glioblasotma radiotherapy treatment with supportive cared had mild improvement in survival compared to supportive care alone. Radiotherapy did not have damaging effect on quality of life or cognitive function in the patients.

Usage, Drug therapy, Radiotherapy, Aged patients, Elderly patients, Glioblastoma multiforme, Clinical report

---

Similar abstracts:

• Abstracts: Treatment for non-Hodgkin's lymphoma in relapse: what are the alternatives? Treatment of non-Hodgkin's lymphoma
• Abstracts: Could antioxidants play a role in high rates of coronary heart disease in the Czech Republic? Geographical differences in CHD mortality in England: implications for local health planning
• Abstracts: Diet revolution: zigzagging your calories for fat loss. Thermogenesis. Burn, baby, burn! Fat, that is
• Abstracts: Small intestinal bacterial overgrowth in patients with rheumatoid arthritis. Cellular immunity to cartilage aggrecan core protein in patients with rheumatoid arthritis and non-arthritic controls
• Abstracts: Serologic screening for syphilis: rationale, cost, and realpolitik. Evaluation of the rapid plasma reagin "teardrop" card test for screening of syphilis in field conditions

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.